Showing results (1-10 of 655) with videos related to
Sort By:
Pageof 66
Revue Medicale De Liege|May 27, 2010
[Fitness versus fatness: respective cardiometabolic impacts at different age ranges]N Esser, N Paquot, A J ScheenRevue Medicale Suisse|October 7, 2011
[Type 2 diabetes and anti-inflammatory agents: new therapeutic prospects?]N Esser, N Paquot, A J ScheenActa Clinica Belgica|June 24, 2015
Inflammatory markers and cardiometabolic diseasesN Esser, N Paquot, A J ScheenDiabetes & Metabolism|March 22, 2015
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose controlA J Scheen, N Esser, N PaquotRevue Medicale Suisse|September 24, 2009
[Metabolically obese normal-weight individuals and metabolically healthy, but obese, subjects]E Beck, N Esser, N Paquot, et al.Revue Medicale De Liege|March 24, 2015
[NLRP3 inflammasome and visceral adipose tissue]N Esser, S Legrand-Poels, J Piette, et al.Revue Medicale De Liege|April 26, 2013
[Clinical evaluation of an obese person]J De Flines, M Rorive, N Esser, et al.Revue Medicale De Liege|June 3, 2022
[Non-alcoholic steatohepatitis (NASH) : a model of metabolic inflammation («metaflammation»)]A J Scheen, F H Luyckx, N Esser, et al.Revue Medicale De Liege|June 5, 2020
[A revolution in the management of type 2 diabetes : antidiabetic agents providing a cardiovascular and renal protection independently of glucose control !]A J Scheen, N PaquotRevue Medicale De Liege|June 7, 2011
[Therapeutic approaches to improve blood glucose control in a patient with type 2 diabetes on a metformin-sulfonylurea combination]A J Scheen, N PaquotPageof 66